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SUMMARY
Interleukin-27 (IL-27) is an immunoregulatory cytokine that suppresses inflammation through 
multiple mechanisms, including induction of IL-10, but the transcriptional network mediating its 
diverse functions remains unclear. Combining temporal RNA profiling with computational 
algorithms, we predict 79 transcription factors induced by IL-27 in T cells. We validate 11 known 
and discover 5 positive (Cebpb, Fosl2, Tbx21, Hlx, and Atf3) and 2 negative (Irf9 and Irf8) Il10 
regulators, generating an experimentally refined regulatory network for Il10. We report two central 
regulators, Prdm1 and Maf, that cooperatively drive the expression of signature genes induced by 
IL-27 in type 1 regulatory T cells, mediate IL-10 expression in all T helper cells, and determine 
the regulatory phenotype of colonic Foxp3+ regulatory T cells. Prdm1/Maf double-knockout mice 
develop spontaneous colitis, phenocopying ll10-deficient mice. Our work provides insights into 
IL-27-driven transcriptional networks and identifies two shared Il10 regulators that orchestrate 
immunoregulatory programs across T helper cell subsets.
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Zhang et al. construct a transcriptional network for IL-27-mediated Il10 production in CD4 T 
cells, characterize the function of 16 Il10 regulators, and uncover the role of two transcription 
factors, Prdm1 and Maf, in driving Il10 production in all T helper cells and in maintaining immune 
homeostasis in the colon.
INTRODUCTION
Interleukin-27 (IL-27) is an immunoregulatory cytokine that regulates immune responses by 
multiple mechanisms, including inhibition of differentiation of effector T cell subsets (Artis 
et al., 2004; Stumhofer et al., 2006; Villarino et al., 2006; Yoshida and Hunter, 2015), 
induction of a “co-inhibitory” gene module to promote T cell exhaustion (Chihara et al., 
2018; DeLong et al., 2019), and polarization of Foxp3+ regulatory T (Treg) cells to a T-bet+ 
subset that specializes in controlling Th1 immunity (Hall et al., 2012). In addition, we and 
others have described that IL-27 can differentiate naive T cells into type 1 regulatory T (Tr1) 
cells (Awasthi et al., 2007; Fitzgerald et al., 2007; Stumhofer et al., 2007; Wang et al., 2011), 
a Foxp3− IL-10-producing regulatory cell population identified in mouse and human, that 
suppresses tissue inflammation, autoimmune reactions, and graft versus host disease 
(GVHD) largely via IL-10 (Roncarolo et al., 1988). IL-27 has the unique capability to 
induce IL-10 production from a wide range of cell types, including Th1, Th2, Th17, and 
Treg cells (Awasthi et al., 2007; Fitzgerald et al., 2007; Hall et al., 2012; Stumhofer et al., 
2006, 2007). Consistent with these observations, Il27ra−/− T cells have defects in producing 
IL-10 in vitro and in vivo (Batten et al., 2008). Il27ra−/− mice suffer from lethal 
immunopathology in parasitic diseases, which is reminiscent of Il10−/− mice (Villarino et al., 
2003), and they are more susceptible to experimental autoimmune encephalomyelitis (Batten 
et al., 2006; Fitzgerald et al., 2007). The molecular mechanisms by which IL-27 induces 
these diverse regulatory functions in T cells are not fully understood.
The anti-inflammatory cytokine IL-10 has an indispensable role in maintaining immune 
tolerance and limiting immunopathology during homeostasis, inflammation, infection, and 
autoimmune diseases (Iyer and Cheng, 2012; Ouyang et al., 2011). Mutations in IL-10 or 
IL-10R lead to early-onset inflammatory bowel disease (IBD) in humans (Shim, 2019), and 
mice deficient in IL-10 or IL-10R develop spontaneous colitis (Kühn et al., 1993; Spencer et 
al., 1998). Importantly, all T helper cell subsets, including Th1, Th2, and Th17 cells, can 
produce IL-10 to mitigate hyperactive immune responses (Gabryšová et al., 2014). Several 
transcription factors (TFs) have been shown to regulate IL-10 (Gabryšová et al., 2014; 
Zhang and Kuchroo, 2019). However, a comprehensive model that systemically examines 
the dynamic transcriptional network that regulates Il10 in a temporal context of induction 
and maintenance is lacking.
Here we combined computational algorithms with high-resolution temporal transcriptional 
profiling to predict the TF network driven by IL-27 during Tr1 differentiation. Network 
analysis systematically identified regulators for Il10 and highlighted Prdm1 and Maf as two 
central nodes of the Il10 regulatory circuits that cooperatively promoted IL-10 production 
not only in Tr1 cells but also in Th1, Th2, Th17, and Treg cells. Genetic deletion of Prdm1 
and Maf in T cells (Prdm1/Maf DKO), but not either alone, led to spontaneous colitis in 
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mice that exhibits features of human IBD, underscoring the importance of Prdm1 and Maf 
crosstalk in regulating immune homeostasis in vivo. Single-cell RNA sequencing (scRNA-
seq) of colonic CD4+ T cells in DKO mice identified a unique cluster of Treg cells that lost 
Il10 expression and acquired proinflammatory signatures.
RESULTS
Building a Predictive Model for the IL-27-Driven Transcriptional Program in CD4 T Cells by 
High-Resolution Temporal Transcriptional Profiling
To understand the gene expression program induced by IL-27 in CD4 T cells, we activated 
naive CD4 T cells in vitro in the presence (Tr1) or absence (Th0) of IL-27 for 72 h and 
performed whole-genome microarrays at 17 time points. 790 genes were differentially 
expressed in Tr1 cells compared with Th0 cells, which partitioned into 24 co-expression 
clusters with distinct temporal profiles (Figure 1A). After activation with IL-27, the cells 
underwent several transcriptional waves before acquiring a stable phenotype (Figure 1B): an 
early phase from 0–4 h, when the global transcriptional profile changes dynamically; a 
stable early phase from 8–20 h; an intermediate phase from 25–42 h; and a late phase from 
48–72 h. The dynamic transcriptional changes during the first 4 h are a distinct feature of 
Tr1 cell differentiation compared with Th17 cells, which manifest a relatively stable profile 
during the early phase from 0–2 h (Yosef et al., 2013).
To identify TFs that drive the distinct transcriptional waves, we hypothesized that genes co-
expressed in a cluster (Figure 1A) are likely to share regulators that are active at the relevant 
time point. We predicted regulator-target associations in the IL-27-driven transcriptional 
programs based on significant overlap between genes in a specific cluster and a regulator’s 
putative targets in a regulator-target association database (Yosef et al., 2013). This generated 
a predictive network containing 79 TFs that were putative regulators of the gene clusters 
induced by IL-27 (Figure 1C). The 79 TFs fall into six major expression patterns, each 
containing both known and previously uncharacterized regulators, that are (1) highly 
expressed during the dynamic early phase (0–4 h), including Irf1 and Batf, which are the 
pioneer TFs of Tr1 cell differentiation (Karwacz et al., 2017), as well as Eomes (Zhang et 
al., 2017); (2) increased during the stable early phase (8–20 h), including Stat1 and Stat3, 
which mediate signaling downstream of the IL-27 receptor (Stumhofer et al., 2007) and 
IL-21 receptor (Leonard and Wan, 2016; Pot et al., 2009); (3) increased during the 
intermediate phase (25–42 h), including Ahr (Apetoh et al., 2010); (4) increased during the 
late phase (48–72 h), such as Prdm1 (Montes de Oca et al., 2016); (5) increased gradually 
over time, such as Maf (Pot et al., 2009) and Hif1a (Mascanfroni et al., 2015); and (6) 
decreased specifically during the stable early phase and may act as gate-keepers for the 
IL-27-induced gene program, which, interestingly, include a potent IL-10 inhibitor, Bhlhe40 
(Huynh et al., 2018; Lin et al., 2014; Yu et al., 2018). Our computational analysis identified 
almost all TFs known to be required for Tr1 cells, indicating a good predictive power, and 
predicted 69 TFs that were not implicated in Tr1 differentiation.
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Experimental Validation of the IL-27 Predicative Network Identifies TFs that Regulate IL-10 
In Vitro
Because IL-10 production is the most representative feature of IL-27-induced Tr1 cells, we 
used IL-10 expression as a readout to validate the predicative IL-27 network. We gathered 
24 available knockout mice, differentiated their naive CD4 T cells into Tr1 cells with IL-27, 
and compared their Il10 mRNA levels with the respective controls (Figure 2A). We validated 
11 known Il10 regulators in T cells: 8 positive regulators (Prdm1, Stat3, Ahr, Maf, Irf1, Batf, 
Hif1a, and Nfil3) and 3 negative regulators (Irf4, Bhlhe40, and Ets1) (Huynh et al., 2018; 
Karwacz et al., 2017; Lee et al., 2012; Lin et al., 2014; Yu et al., 2018). We found that 
Cebpb, a TF that induces ll10 in M2 macrophages (Liu et al., 2003), was also required for 
Il10 production in Tr1 cells. Importantly, among the 12 tested factors that were not known to 
regulate Il10, we discovered 4 positive (Atf3, Fosl2, Tbx21, and Hlx) and 2 negative (Irf9 
and Irf8) Il10 regulators. These TFs also regulated IL-10 at the protein level (Figure S1A). 
Of the 24 genetically perturbed TFs, we successfully validated 18 (75%) of our 
computational predictions.
We examined binding of the aforementioned Il10 regulators to the Il10 locus in public 
chromatin immunoprecipitation sequencing (ChIP-seq) data. ATF-3 (Garber et al., 2012), T-
bet (Nakayamada et al., 2011), Fosl2 (Ciofani et al., 2012), and IRF8 (Xu et al., 2015) have 
significant binding in the Il10 locus, some of which lies in chromatin-accessible regions in 
Tr1 cells (Figure 2B), indicating that they may directly regulate Il10 transcription in Tr1 
cells. To investigate whether these TFs can trans-activate or inhibit Il10, we performed 
luciferase reporter assays in 293T cells using reporters for the proximal Il10 promoter and 
the CNS-9, HSS+2.98, and HSS+6.45 enhancers (Hedrich and Bream, 2010; Figure 2C). 
Atf3, Fosl2, and Hlx transactivated the Il10 promoter and the three enhancers. 
Transactivation by Cebpb was more restricted to the promoter and CNS-9 region, and T-bet 
only transactivated the CNS-9 region. Irf8 inhibited the baseline activity of the Il10 
promoter, HSS+2.98, HSS+6.45, and, to a lesser extent, CNS-9. We found that 
transactivation of Il10 by the pioneer factor Irf1 (Karwacz et al., 2017) was completely 
blocked by Irf8 co-expression at the three enhancers but not the proximal promoter (Figure 
S1B). In contrast, the putative negative regulator Irf9 transactivated Il10 at all four cis-
regulatory sites, indicating that inhibition of Il10 by Irf9 in Tr1 cells may be mediated by 
indirect mechanisms (Figure 2C). In summary, we validated 11 known and discovered 7 
direct and indirect regulators of Il10 during IL-27-driven Tr1 differentiation.
Hlx Regulates Il10 Expression and Tr1 Function In Vivo
It has been shown previously that Hlx cooperates with T-bet to promote interferon (IFN)-
γexpression in Th1 cells in vitro (Mullen et al., 2002); however, whether it regulates T cell 
function in vivo and whether it has an immunoregulatory role has not been investigated. To 
address these questions, we first tested the role of Hlx in a model of self-limiting 
inflammation induced by intraperitoneal injection of an anti-CD3 antibody, which 
spontaneously resolves in a IL-10-dependent manner (Huber et al., 2011; Kamanaka et al., 
2006). Because Hlx deficiency is embryonically lethal (Hentsch et al., 1996), we compared 
Il10 expression in CD4 T cells from Hlx+/− and WT mice following anti-CD3 injection and 
observed less Il10 in Hlx+/− T cells (Figure 2D). We next investigated how Hlx regulates the 
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immunoregulatory function of Tr1 cells in a T cell transfer colitis model. Rag−/− mice 
receiving wild-type (WT) Tr1 cells were able to maintain their body weight because Tr1 
cells normally do not induce colitis. However, the recipients of Hlx+/− Tr1 cells lost weight 
over time, indicating that Tr1 cells haplodeficient for Hlx might lose the regulatory 
phenotype and become proinflammatory (Figure 2E).
A Comprehensive Transcriptional Network Focused on Regulation of IL-10 by IL-27
We identified causal genetic targets of the Il10-regulating TFs in the IL-27 network by 
performing RNA-seq on Tr1 cells genetically deficient in each of them, generating a 
comprehensive network showing the effect of the TFs on Il10 as well as on the expression of 
each other (Figure 3A). The network showed dense inter-connectedness between multiple 
negative and positive Il10 regulators, with substantial cross-regulation between them, 
explaining how indirect regulators affect Il10 expression through direct regulation of other 
regulators (Figure 3A). Besides direct inhibition of Il10 by Irf8, the negative regulators, 
including Irf8, Irf4, Ets1, and Irf9, may regulate Il10 by inhibiting the expression of positive 
regulators such as Prdm1, Maf, Ahr, and Batf. Except for inhibition of Irf4 by Stat1 and 
Bhlhe40 by Maf, very few positive regulators inhibited expression of the negative regulators; 
rather, they reinforced the expression of each other. Quantification of TF connectivity within 
the network by betweenness centrality score revealed Prdm1 and Maf as the most central 
positive regulators and Irf4 as the most central negative regulator, identifying these TFs as 
central hubs for regulation of Il10 in Tr1 cells (Figure 3B).
We observed three distinct phases of Il10 expression during Tr1 differentiation from the 
temporal microarray data (Figure 3C): a latency phase (0–20 h) with no detectable Il10, an 
induction phase (20–48 h), and a maintenance phase (48–72 h). To further understand the 
temporal dynamics of Il10 regulation, we divided the global network into three phase-
specific networks based on the regulator’s temporal expression pattern (Figure 3D). The 
IRFs and Atf3 were mainly increased during the latency phase; Hlx during the induction 
phase; Tbx21, which has been shown to cooperate with Hlx (Mullen et al., 2002), at the 
latency and induction phase; and Fosl2, during the late induction phase and the maintenance 
phase. Notably, Prdm1, Maf, and Cebpb were increased at all three phases. Multiple 
regulators that suppress Il10 were expressed at the latency phase and decreased at the 
induction and maintenance phases. This may be one of the reasons why Il10 induction is 
relatively late during Tr1 differentiation.
Prdm1 and Maf Have Complementary but Indispensable Roles in Regulating Tr1 Identity at 
the Transcriptional and Chromatin Level
Despite being the most central nodes in the Il10 regulatory network, Il10 expression in 
Prdm1 or Maf single-knockout (cKO) Tr1 cells is only partially reduced, suggesting a 
complementary relationship between the two TFs. We therefore generated mice that lack 
both Prdm1 and Maf (DKO) in T cells, using conditional deletion driven by Cd4-Cre. 
Prdm1/Maf double deficiency led to almost complete loss of Il10 in Tr1 cells (Figure 4A).
To investigate how loss of Prdm1 and Maf influences the Il10 regulatory network (Figure 
3A), we performed RNA-seq on single- and double-KO Tr1 cells at 72 h (Figure 4B). 
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Deficiency in Prdm1 and Maf led to a collapse in expression of several TFs important for 
Il10 expression, including Fosl2, Hif1a, Hlx, and Notch1 (Rutz et al., 2008), which was not 
observed in Prdm1 or Maf single KO. In addition, a number of other transcriptional 
regulators that are induced by IL-27 were also specifically decreased in DKO cells, such as 
Sp1, Ets2, Mbnl3, Klf10, Nfyb, Satb1, Crem, Nfkbia, Chd7, Trim25, Klf6, and Nfkb2, 
although their role in regulating Il10 remains to be investigated. Furthermore, Prdm1 and 
Maf transcriptionally regulated each other’s expression (Figure 4B). Bhlhe40, a potent Il10 
inhibitor, was increased dramatically in DKO mice, indicating that Prdm1 and Maf are 
critical not only for driving Il10 expression but also for antagonizing the expression of TFs 
that repress Il10. Although some positive regulators, such as Irf1 and Atf3, were increased in 
DKO cells, these early-stage Il10 inducers could not rescue the loss of Il10 in the absence of 
Prdm1 and Maf, perhaps because of their inability to overcome inhibition (Figure S1B).
To assess whether Prdm1 or Maf regulated the chromatin landscape of Tr1 cells, we profiled 
chromatin accessibility in single- and double-KO Tr1 cells using Assay for Transposase-
Accessible Chromatin with high-throughput sequencing (ATAC-seq). Although the 
chromatin landscape in the Il10 locus remains largely unchanged in Prdm1 or Maf single-
KO cells, we detected a reduction in accessibility at specific enhancer regions in the Il10 
locus in DKO cells (Figure 4C). In addition, we found that Fosl2 and Hlx, two other positive 
regulators of Il10, also became less accessible in DKO but not either single-KO cells (Figure 
4C), which is consistent with their gene expression profile. Moreover, DKO Tr1 cells 
showed a unique reduction in chromatin accessibility in co-inhibitory receptor gene loci 
such as Ctla4, Pdcd1 (PD-1), Tigit, Havcr2 (Tim-3) (Figure S2), another hallmark of Tr1 
cells that is transcriptionally regulated by Prdm1 and Maf (Chihara et al., 2018). In 
summary, these data suggest that Prdm1 and Maf have complementary but indispensable 
roles in regulating the hallmark genes for Tr1 identity at the transcriptional and chromatin 
levels.
IL-10 Regulators Are Induced in Diverse IL-10-Producing T Helper Cells
All T helper cells can produce IL-10, but the regulation of IL-10 expression in these contexts 
is unclear. We therefore examined whether the regulators we identified in the IL-27 network 
were also utilized for IL-10 regulation in other T helper cells. We differentiated naive CD4 T 
cells from IL-10Thy1.1 reporter mice (10BiT) (Maynard et al., 2007) into Th1, Th2, non-
pathogenic Th17 (Th17), pathogenic Th17 (pTh17), and Tr1 cells; sorted out the IL-10+ and 
IL-10− compartments; and performed RNA-seq. We also analyzed the RNA profiles of 
IL-10+ versus IL10− T cells purified from several other in vivo and in vitro conditions (Boks 
et al., 2016; Burton et al., 2014; Gagliani et al., 2015; Langenhorst et al., 2012; Neumann et 
al., 2014; Trandem et al., 2011; Table S1). We identified TFs whose expression was 
associated with IL-10 in each T cell subset or condition (Figures 5A and 5C) and ranked 
them based on the number of conditions where their expression is enriched in the IL-10-
producing compartment (Figures 5B and 5D). Many of the regulators identified in our IL-27 
network were also identified by this analysis, including Prdm1, Maf, Hlx, Tbx21, Batf, 
Nfil3, Ahr, Bhlhe40, and Irf8, indicating that they might also regulate IL-10 in other 
contexts (Figures 5A and 5C). Prdm1 and Maf, the two positive regulators with highest 
centrality in the IL-27 network (Figure 3B), were enriched in the IL-10-producing 
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compartment of all T helper cell subsets (Figure 5B) as well as under many other in vivo and 
in vitro conditions (Figure 5D), whereas the other TFs were more restricted to certain 
conditions. A combined ranking scheme of IL-10 regulators evaluating the centrality score 
in the IL-27 network and generalizability in other IL-10-producing T cell subsets derived 
from in vitro and in vitro contexts revealed Prdm1 and Maf as the two top TFs that regulate 
IL-10 production across T helper cells (Figure 5E).
Role of Prdm1 and Maf in Regulating IL-10 in Different T Helper Cells
We validated the association of Prdm1 and Maf expression with Il10 in various contexts by 
qPCR. The IL-10+ compartment of Th1, Th2, Th17, Tr1, and Treg cells expressed higher 
levels of Prdm1 and Maf than their IL-10− counterparts (Figure 6A). Moreover, analysis of 
public ChIP-seq datasets confirmed binding of Prdm1 and Maf at accessible chromatin 
regions in the Il10 locus (Figure 6B). These findings further support the hypothesis that 
Prdm1 and Maf may be critical regulators of IL-10 in multiple settings.
We tested the interaction between Prdm1 or Maf in regulating Il10 using luciferase assays. 
Although Prdm1 alone had very limited capability to transactivate Il10, it significantly 
enhanced transactivation of Il10 by Maf (Figure 6C), suggesting that cooperation between 
Prdm1 and Maf is required for optimal IL-10 production. Of note, the synergistic effect 
between Prdm1 and Maf is specific to enhancer regions (tested by the interaction term in the 
linear regression model; CNS-9, p = 0.00255; HSS+6.45, p = 0.000154) but not the 
promoter. We further studied the synergy between Prdm1 and Maf in regulating Il10 in 
primary CD4 T cells using a gain-of-function approach by transducing Th1, Th2, Th17, Tr1, 
and Treg cells with retroviruses encoding Prdm1 (MSCV-IRES-Thy1.1) and Maf (MSCV-
IRES-GFP). IL-10 production was enhanced dramatically when Prdm1 and Maf were co-
expressed (Figure 6D). Importantly, although Prdm1 and Maf cooperatively promoted IL-10 
production across all T helper cells, they did not inhibit production of signature cytokines of 
the T helper cell subsets (Figure S3). Thus, Prdm1 and Maf enabled expression of a gene 
module that induced IL-10 in all T helper cell subsets without disrupting their cell 
differentiation program.
Genetic Deficiency of Prdm1 and Maf, but Not Either Alone, in T Cells Leads to Human IBD-
like Spontaneous Colitis Driven by a Unique Cluster of Treg Cells
IL-10 has a critical role in maintaining intestinal homeostasis. Mutations in IL-10 or IL-10R 
are associated with human ulcerative colitis presenting in early childhood (Zhu et al., 2017). 
We therefore monitored Prdm1/Maf DKO mice for spontaneous development of colitis. 
Strikingly, loss of Prdm1 and Maf in T cells led to spontaneous weight loss over time 
(Figure 7A), similar to that observed in IL-10-deficient mice (Kühn et al., 1993). The 
presence of one copy of the Maf allele protected the mice from weight loss until 16 weeks of 
age, and one copy of Prdm1 protected the mice until at least 24 weeks of age (Figure S4A). 
DKO mice, but not single-KO mice, had shorter colons (Figure 7B), and histological 
analysis of the entire intestine confirmed the presence of active colitis in DKO mice (Figure 
7C; Figure S4B) with features reminiscent of human ulcerative colitis. Severe chronic active 
colitis with cryptitis, crypt abscess, and crypt loss with mucosal ulcers reminiscent of 
ulcerative colitis was the most prevalent pathology in DKO mice. DKO mice occasionally 
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showed flask-shaped aphthous erosions that are common in human Crohn’s disease, but 
other defining features of Crohn’s disease, such as transmural lymphoid aggregates, were 
absent in all mice (Figure 7C; Figure S4C). Although Cd4-Cre; Prdm1fl/fl mice have been 
reported to develop spontaneous colitis (Martins et al., 2006), we observed spontaneous 
intestinal disease very rarely only in male but not in any female mice. Moreover, the 
pathology in these mice was mainly located in the proximal end of the small intestine rather 
than the colon (Figures S4D and S4E).
To characterize the transcriptional changes in T cells that lead to spontaneous colitis in DKO 
mice, we performed scRNA-seq on CD4 T cells from the colonic lamina propria at 3 weeks 
of age before disease onset. We included two biological replicates for each genotype (Figure 
7D) and collected a total of 13,535 high-quality single-cell profiles that were partitioned into 
eight distinct clusters (Figure 7E). Cluster identity was designated based on bulk RNA-seq-
derived gene signatures (Immgen) and confirmed by expression of key marker genes 
(Figures S5A and S5B). Cells of the four genotypes distributed evenly within the naive T 
cell clusters (clusters 1–3), indicating negligible batch effects between samples and similar 
phenotypes of naive T cells in the absence of Prdm1 or Maf. However, Maf cKO and DKO 
cells formed distinct sub-clusters within the effector T cell cluster (cluster 4), and each of the 
Treg cell clusters (clusters 5–8) was dominated by a different genotype (Figures 7D-7F; 
Figure S5C).
The proportion of effector T cells was increased in both Maf cKO and DKO (Figure 7F), but 
these cells were qualitatively different (Figures 7G and 7H) in that DKO effector cells had 
dramatically increased expression of the Th1 gene signature, which is a major pathogenic 
cell population implicated in IBD (Ito and Fathman, 1997; Neurath et al., 2002). The Th17 
gene signature was also increased significantly in DKO but to a lesser extent (Figure 7G). A 
subset of effector cells in DKO mice acquired a signature that resembles CD4 T cells from 
inflamed intestinal lesions of humans with ulcerative colitis (Smillie et al., 2019). In 
addition, the differentially expressed genes in DKO effector T cells (compared with control 
cells) showed unique enrichment for IBD-associated genome-wide association study 
(GWAS) genes that are involved in adaptive immunity (Graham and Xavier, 2020; Figure 
7H). These data indicate that loss of Prdm1 and Maf leads to spontaneous colitis that 
resembles human IBD in terms of not only pathological features but also molecular 
signatures.
Consistent with previous reports (Maynard et al., 2007), Treg cells (clusters 7 and 8) were a 
major source of IL-10 in the colon (Figure 7I). We observed that the average expression 
level of Il10 was reduced in colonic Treg cells in the absence of Maf; the average expression 
level and percentage of Il10-positive cells were reduced in the absence of Prdm1, and Il10 
expression was barely detectable in the absence of both (Figure 7J). Therefore, Prdm1 and 
Maf were also required for Il10 expression in Treg cells in vivo.
Besides downregulation of Il10, DKO Treg cells, compared with single-KO or control Treg 
cells, exhibited a unique gene expression profile (cluster 5; Figures 7D-7F). DKO Treg cells 
lost immunoregulatory phenotypes, including expression of TFs critical for Treg cell 
stability and function (e.g., Ikzf2 and Gata3), co-stimulatory receptors (e.g., Cd28, Tnfrsf18, 
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and Tnfrsf4), and soluble immunosuppressive molecules (e.g., Areg and Apoe). On the other 
hand, DKO Treg cells acquired Th1- associated (e.g., Nkg7, Xcl1, Lta, and Cxcl10) and 
Cytotoxic T Lymphocytes (CTL)-associated (e.g., Cd160 and Gpr18) genes that are known 
to actively promote inflammation. Moreover, DKO Treg cells showed profound changes in 
their chemotaxis profile, turning off Ccr2 and Cxcr6 while dramatically upregulating Ccr7 
(Figure 7K). These data indicated that Prdm1 and Maf cooperatively regulate the identity 
and function of Treg cells and are indispensable for immune tolerance in vivo.
DISCUSSION
Computational inference of gene regulation from temporal profiling of gene expression has 
shown great potential to delineate the dynamic transcriptional circuits that regulate T cell 
differentiation. We and others have successfully built models of regulatory networks for 
Th17 cells (Wu et al., 2013; Yosef et al., 2013; Ciofani et al., 2012) and Th2 cells 
(Henriksson et al., 2019), discovering key regulators and revealing general principles 
governing T cell differentiation. Here we computed a transcriptional network induced by 
IL-27 in CD4 T cells that showed strong predicative power for identification of Il10 
regulators: 18 (75%) of the 24 predicted TFs we validated experimentally were confirmed to 
be regulating Il10 expression. In addition to IL-10, IL-27-induced Tr1 cells feature 
expression of IFN-γ (Awasthi et al., 2007; Pot et al., 2009) and co-inhibitory receptors 
(Chihara et al., 2018; DeLong et al., 2019). Therefore, the predicted TFs in the IL-27 
network presented here could also be utilized for defining the transcriptional regulation of 
these molecules in a manner similar to what is presented here for Il10.
By genetically perturbing the IL-27 network, we identified critical regulators of Il10, which 
may shed light on previously unappreciated roles of IL-10 in physiological processes and 
deepen our understanding of IL-10-related immune disorders such as IBD (Zhu et al., 2017). 
For example, Atf3 is a TF that is induced by endoplasmic reticulum stress (Schmitz et al., 
2018) with anti-inflammatory properties (De Nardo et al., 2014; Gilchrist et al., 2006); 
induction of IL-10 by Atf3 may provide a negative feedback loop to dampen endoplasmic 
reticulum (ER) stress (Hasnain et al., 2013; Shkoda et al., 2007) and suppress inflammation. 
Further, Fosl2 is a member of the AP1 family, which contains several members that were 
implicated in Il10 regulation (Hu et al., 2006; Kremer et al., 2007). Fosl2 has been shown 
previously to regulate the pathogenicity of Th17 cells (Ciofani et al., 2012), which play an 
important role in the pathogenesis of IBD. A single-nucleotide polymorphism (SNP) in 
Fosl2 (rs925255) has been linked genetically to IBD in a GWAS (Jostins et al., 2012). Our 
study raises the possibility that the SNP in Fosl2 may further influence susceptibility to IBD 
by regulating IL-10 expression. Last, we identified Hlx as a regulator of IL-10 and showed 
that its haplodeficiency is sufficient to convert Tr1 cells to proinflammatory cells that 
exacerbate T cell transfer colitis. Interestingly, the Hlx locus has been shown to be 
hypermethylated in epithelial cells in humans with IBD, and these data suggest that Hlx 
might have a role in regulating immune responses beyond T cells.
The lineage-defining TFs for Th2 (GATA-3) and Th17 (ROR-γt) have been shown to 
contribute to IL-10 expression (Shoemaker et al., 2006; Wang et al., 2015). However, the 
role of T-bet, the master TF for Th1 cells, in Il10 regulation has been controversial. One 
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study has reported that IL-10 production is increased in CD4 T cells in the absence of T-bet 
(Shin et al., 2014), which could be due to the indirect effect of a decrease in IFN-γ (Hu et 
al., 2006). Other studies have reported that T-bet can induce IL-10 production but under 
conditions where T-bet or other TFs are overexpressed (Rutz et al., 2008; Zhu et al., 2015). 
Here we show that genetic deficiency in T-bet leads to impaired IL-10 production in Tr1 
cells. Additionally, we show, by ChIP-seq and luciferase assays, that T-bet can directly bind 
and transactivate Il10. Thus, the master TFs for all T helper cell subsets can induce 
immunoregulatory genes to mitigate overexuberant responses. Eomes, another T-box TF that 
is highly homologous to T-bet in its DNA binding domain (Pearce et al., 2003), has been 
reported to regulate IL-10 in a GVHD model (Zhang et al., 2017). Our study suggests that 
the relative contribution of these two TFs to IL-10 regulation may be highly context 
dependent (Zhang et al., 2017).
Master TFs have been identified for other T cell subsets but not for Tr1 cells. Our network 
analysis in Tr1 cells highlighted Prdm1 and Maf as central hubs in regulating Il10. Not only 
are they heavily regulated, but, more importantly, they orchestrate a regulatory circuit 
composed of multiple other transcriptional modulators. Prdm1/Maf DKO Tr1 cells, but not 
either single KO Tr1 cells, exhibited complete loss of Il10 and collapse of the Il10 regulatory 
circuit, both accompanied by reduced chromatin accessibility, and a notable upregulation of 
the Il10 repressor Bhlhe40. Expression of co-inhibitory receptors, another hallmark of Tr1 
cells (Brockmann et al., 2018; Chihara et al., 2018; DeLong et al., 2019), are induced by 
IL-27 and controlled by Prdm1 and Maf transcriptionally and at the chromatin level. These 
data suggest that the key signature of Tr1 cells might be established through collaboration 
between two TFs with complementary roles.
We and others have shown that c-Maf is a universal regulator of IL-10 in Th1, Th2, Th17, 
Tr1, as well as Treg cells (Gabryšová et al., 2018). Further, we discovered that Maf needs to 
cooperate with other TFs, such as Ahr, to achieve robust Il10 transcription (Apetoh et al., 
2010). In this study, we identified Prdm1 as a critical partner of Maf and that together they 
synergistically transactivate Il10 in all CD4 T cell subsets, including IL-10-producing Tr1 
cells.
Commitment of T helper cells to specific subsets requires induction of master TFs that not 
only induce specific transcriptional programs that push T cell subsets in one direction but 
also initiate repressive programs that antagonize other fates (Sungnak et al., 2019). 
Interestingly, we observed that, although Prdm1 and Maf synergistically promote IL-10 
production, they do not inhibit production of signature cytokines of the different T helper 
cell subsets, enabling them to co-produce IL-10 while maintaining their original 
transcriptional program.
We found that Prdm1/Maf DKO mice, but not single KO mice, phenocopy Il10-deficient 
mice and develop spontaneous colitis that presents pathological and molecular features of 
human IBD. Prdm1 is a well-recognized GWAS gene associated with IBD (Ellinghaus et al., 
2013). It would therefore be interesting to investigate whether SNPs related to Maf can 
further enhance IBD susceptibility. With scRNA-seq analysis, we discovered a unique 
cluster of colonic Treg cells in Prdm1/Maf DKO mice that was not observed when Prdm1 
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(Cretney et al., 2011; Garg et al., 2019; Ogawa et al., 2018) or Maf (Neumann et al., 2019; 
Xu et al., 2018) was perturbed individually. These DKO Treg cells lose immunoregulatory 
phenotypes, including production of IL-10, and acquire strong Th1- and CTL-associated 
gene signatures, indicating potential to actively exacerbate inflammation. In addition, this 
DKO Treg cell cluster shows a profound shift in the use of chemokine receptors from those 
that drive T cells to tissue with active inflammation (e.g., Ccr2 and Cxc6) (Hamano et al., 
2014; Loyher et al., 2016; Mondini et al., 2019; Zhang et al., 2009) to Ccr7, which, together 
with two other markers highly expressed by DKO Treg cells, Lta (Upadhyay and Fu, 2013) 
and Itgae (Leithäuser et al., 2006), are associated with development of lymphoid-like 
structures. Therefore, it would be interesting to further study how Prdm1 and Maf regulate 
the migration and location of Treg cells.
We have shown that Prdm1 and Maf co-operatively induce the co-inhibitory receptor gene 
module on exhausted CD8 T cells (Chihara et al., 2018), which not only have a 
dysfunctional effector program but also co-produce IL-10 to actively suppress the immune 
responses in chronic viral infections and cancer. Further, Maf was also implicated in IL-10 
expression in B cells (Liu et al., 2018) and macrophages (Cao et al., 2005), and Prdm1 has a 
regulatory role in dendritic cells (Kim et al., 2011; Watchmaker et al., 2014). These data, 
together with our current study, emphasize the importance of cooperativity between Prdm1 
and Maf in regulating immunoregulatory gene programs across multiple immune cell types.
STAR★METHODS
RESOURCE AVAILABILITY
Lead Contact—Further information and requests for resources and reagents should be 
directed to and will be fulfilled by the Lead Contact, Vijay Kuchroo 
(vkuchroo@evergrande.hms.harvard.edu).
Materials Availability—This study did not generate new unique reagents.
Data and Code Availability—Data generated in this paper has been deposited in the 
Gene Expression Omnibus (GEO) under accession number GEO: GSE159208.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice and Ethics Statement—C57BL/6, BALB/cJ, dLckCre, Hlx+/− (Hentsch et al., 
1996), Tbx21−/− (Finotto et al., 2002), Irf8fl/fl (Feng et al., 2011), Prdm1fl/fl (Shapiro-Shelef 
et al., 2003), Nfe2l2−/− (Chan et al., 1996), Hif1afl/fl (Ryan et al., 2000), Ahr−/− (Schmidt et 
al., 1996), Batf3−/− (Hildner et al., 2008), Stat3fl/fl (Moh et al., 2007), Stat4−/− (Kaplan et al., 
1996), Irf1−/− (Matsuyama et al., 1993), Batf−/− (Schraml et al., 2009), Irf4fl/fl (Klein et al., 
2006), Bhlhe40−/− (Jiang et al., 2008) and 10BiT (Maynard et al., 2007) mice were 
purchased from Jackson Laboratory. Cd4Cre (Lee et al., 2001) mouse was purchased from 
Taconic. Maffl/fl (Wende et al., 2012), Nfil3fl/fl (Gascoyne et al., 2009), Id2fl/fl (Seillet et al., 
2013), Ets1−/− (Muthusamy et al., 1995) and Foxp3-GFP mouse (Bettelli et al., 2006) has 
been previously described. Other previously described mutant strains were kindly provided 
by the following researchers: Fosl2fl/fl (Karreth et al., 2004), D. Littman; Atf3fl/fl Actb-
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Cre(Taketani et al., 2012), H. Weiner; Cebpbfl/fl Lck-Cre+ (Sterneck et al., 2006), M. 
Rincon. In addition, spleens from Irf7−/−, Fli1+/−, Irf9−/− mice were obtained from Ian R. 
Rifkin, Maria Trojanowska, and Paul J. Utz, respectively. In vitro experiments were 
performed using 6-10 weeks old female and male mice.
All animals were housed and maintained in conventional pathogen-free facilities at the 
Harvard Institute of Medicine and Hale Building for Transformative Medicine in Boston 
(IUCAC protocols: 2016N000444 (V.K.K.)). All experiments were performed in accordance 
to guidelines outlined by Harvard Medical Area Standing Committee on Animals and the 
Brigham and Women’s Hospital Institutional Animal Care and Use Committee.
METHOD DETAILS
Experimental methods
T cell sorting and in-vitro T helper cell differentiation: For the generation of time-course 
microarray data of Tr1 cells and validation of Il10 regulators in Tr1 cells in vitro, 
CD4+CD44−CD62L+CD25− naive cells were sorted from WT B6 or indicated KO and their 
corresponding control mice with BD FACSAria sorter, and then activated with plate-bound 
anti-CD3 and anti-CD28 (both at 1ug/ml) in the presence of 25ng/ml rmIL-27 (R & D 
systems). 10ug/ml anti-TGFβ (Bioxcell, Clone# 1D11.16.8) was also added for the 
microarray experiment.
For RNA-seq and qPCR analysis of IL-10 producing and non-producing T helper cells, 
naive CD4+CD44−CD62L+GFP− cells were sorted from Foxp3-GFP; Il10-Thy1.1 double 
reporter mice using BD FACSAria sorter and were activated with irradiated splenocytes 
depleted of CD4 T cells (at the T: APC ratio of 1:6) and 2.5ug/ml soluble anti-CD3 in the 
presence of polarizing cytokines. Concentration of cytokines are as follows: 20ng/ml 
rmIL-12 (R & D systems) for Th1; 20ng/ml rmIL-4 (Miltenyi Biotec) for Th2; 2ng/ml of 
rhTGFb1 and 25ng/ml rmIL-6(both from Miltenyi Biotec) for non-pathogenic Th17; 
20ng/ml rmIL-1β(Miltenyi Biotec), 25ng/ml rmIL-6 (Miltenyi Biotec), and 20ng/ml 
rmIL-23 (R&D systems) for pathogenic Th17; 25ng/ml of rmIL-27 (R & D systems) for 
Tr1. IL-10 positive (Thy1.1+) and negative (Thy1.1+) 7-AAD−TCRβ+CD4+GFP− cells were 
re-sorted at 72 hours.
Isolation of lymphocytes from colonic lamina propria: To remove epithelial cells, colons 
were first washed for 20min in RPMI medium (GIBCO) with 3% FBS (Sigma-Aldrich), 
5mM EDTA (Invitrogen) and 1mM DTT (Sigma) in a shaking incubator at 400rpm at 37°C, 
followed by three other washes each for 30 s by vibrant vortexing in RPMI with 2mM 
EDTA. The tissue was then cut into little pieces and digested for 30min in RPMI with 
100ug/mL Liberase TL (Sigma) and 500ug/mL DNase I (Sigma) Digestion in a shaking 
incubator at 400rpm at 37°C. Digestion was terminated by addition of ice-cold RPMI with 
3% FCS. Cells were washed twice in RPMI with 3% FCS, passed through a 40μm cell 
strainer and resuspended in ice-cold RPMI with 3% FCS and 1mM EDTA for sorting.
RNA profiling by microarrays, population RNA-seq and single cell RNA-seq: The 
temporal gene expression profiling of Tr1 cells at 17 time points during in vitro 
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differentiation by IL-27 were measured by Affymetrix GeneChip Mouse Genome 430 2.0 
Arrays. For genetic validation of the 24 TFs, naive CD4+ T cells were isolated from spleen 
of knockout mice and matched controls and differentiated in vitro in Tr1 polarizing 
conditions for 72 hours. Cells were collected and processed using an adaptation of the 
SMART-Seq 2 protocol (Tirosh et al., 2016), using 5uL of lysate from bulk CD4+ T cells as 
the input for each sample during RNA cleanup via SPRI beads (~2,000 cells lysed on 
average in RLT). Libraries were prepared using the Nextera XT DNA Sample Prep Kit 
(Illumina), quantified, pooled, and then sequenced on the HiSeq 2500 (Illumnia) to an 
average depth of 20M reads.
For scRNA-seq profiling of colonic CD4 T cells in control, Prdm1 cKO, Maf cKO, and 
DKO mice, live (7-AAD−) TCRβ+CD4+ cells were sorted from colonic lamina propria of 
each mouse with two biological replicates for each genotype. Cells were processed using 
Chromium Single Cell 3′ Reagent Kits v2 according to manufacturer’s protocol (10X 
Genomics). For each biological replicate, an input of 7,000 single cells was added to an 
individual channel with a recovery rate of approximately 1,300~2100 cells. The generated 
scRNA-seq libraries were sequenced on HiSeq X Ten.
ATAC-seq: Control, Prdm1 cKO, Maf cKO, and DKO Tr1 cells were cultured as described 
above for 72h with IL-27. Three to five replicates were included for each genotype. 
Subsequently, 6,000 viable Tr1 cells were sorted and frozen in BambankerTM cell freezing 
media (LYMPHOTEC Inc.) at 80°C. For ATAC-seq library preparation, cells were thawed at 
37°C, washed once with PBS, and lysed and tagmented in 1X TD Buffer, 0.2ml TDE1 
(provided in Nextera® DNA Sample Preparation Kit from Illumina), 0.01% digitonin, and 
0.3X PBS in 40ml reaction volume following the protocol described by Corces et al. (2016). 
The DNA was purified immediately with the MinElute PCR purification kit (QIAGEN), and 
then PCR amplified and quantified as we previously described (Wallrapp et al., 2019). The 
library was sequenced on an Illumina NextSeq 550 system with paired-end reads of 37 base 
pairs in length.
Quantitative RT-PCR: RNA was extracted using RNeasy Plus Mini Kit (QIAGEN), cDNA 
was prepared using iScript Reverse Transcription Supermix (Bio-rad) and used as template 
for real-time qPCR run with TaqMan Fast Advanced Master Mix (Thermo Fisher Scientific) 
on the ViiA 7 Real-Time PCR System (Applied Biosystems). Expression was normalized to 
Actb. The following probes used for qPCR were purchased from Applied Biosystems: Il10 
(Mm01288386_m1), Maf (Mm02581355_s1), Prdm1 (Mm00476128_m1), Actb 
(Mm00607939_s1).
Flow Cytometry: Single cell suspensions were stained with antibodies against surface 
molecules. Fixable viability dye eF506 or 7-AAD was used to exclude dead cells. For intra-
cytoplasmic cytokine staining, cells were stimulated with 12-myristate 13-acetate (PMA) 
(50ng/ml, Sigma), ionomycin (1 μg/ml, Sigma) in the presence of Brefeldin A (Golgiplug, 
BD Biosciences) and Monensin (Golgistop, BD Biosciences) for 4-5 hours prior to staining 
with antibodies against surface proteins followed by fixation, permeabilization with 
Fixation/Permeabilization Solution Kit (BD Biosciences) and staining with antibodies 
against intracellular cytokines. Data was analyzed with Flowjo.
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Luciferase assays: 5x104 293T cells were seeded in 96 well plate one day before 
transfection and then transfected with Firefly luciferase reporter constructs for Il10, Renilla 
luciferase reporter (internal control) and plasmids expressing specific transcription factors 
using PolyJet In Vitro DNA Transfection Reagent (SignaGen Laboratories). Cells were 
analyzed 48h later with Dual-Luciferase Reporter Assay System (Promega). To construct 
reporters for Il10 enhancers, previously described enhancer regions, including the CNS-9, 
HSS+2.98, and HSS+6.45 (Lee et al., 2009), were cloned upstream of the Il10 minimal 
promoter. Fragments containing the proximal Il10 promoter (−1.5 kb including the 
HSS-0.12 site) or the aforementioned enhancers were cloned into pGL4.10 Luciferase 
reporter plasmid (Promega).
In-vivo treatment of anti-CD3: Mice were treated with 20 μg anti-CD3 monoclonal 
antibody (clone 145-2C11, Bio X Cell) or an isotype control (Bio X Cell) intraperitoneally 
every 3 days for a total of three times. Mice were sacrificed 4h after the last treatment. CD4 
T cells were purified from mesenteric lymph node by MACS® cell separation and Il10 
expression was measured by qPCR.
T cell transfer colitis: CD4+CD62L+ T cells were sorted from WT and Hlx+/− mice and 
cultured with plate-bound anti-CD3 and anti-CD28 antibody in the presence of 25ng IL-27. 
72 h later cells were detached from the plate and rested for 48h before transferred into 
Rag1−/− recipients. 5 × 105 WT or Hlx heterozygous Tr1 cells were transferred 
intraperitoneally into Rag1−/− animals and changes in body weight were monitored weekly.
Retroviral infection: T cells activated with plate-bound anti-CD3 and anti-CD28 antibody 
in the presence of polarizing cytokines were transduced with MSCV expressing Prdm1 
(marked by Thy1.1) and Maf (marked by GFP) at 24h after activation. IL-10 expression in 
control (Thy1.1−GFP−), Prdm1-overexpressing (Thy1.1+GFP−), Maf-overexpressing 
(Thy1.1−GFP+) and cells overexpressing both (Thy1.1+GFP+) was analyzed by flow 
cytometry. For preparation of retroviruses, Plat-E cells were transfected with MSCV vectors 
with PolyJet. Supernatant containing virus was harvested 48hr after transfection of Plat-E 
cells and then used for spin transduction of T cells with polybrene (8 μg/ml) at 2000rpm, 
32°C for 1hr.
Computational Methods
Microarray data pre-processing and analysis: Individual .CEL files were RMA 
normalized and merged to an expression matrix using the ExpressionFileCreator of 
GenePattern with default parameters (Reich et al., 2006). Gene-specific intensities were then 
computed by taking for each gene j and sample i the maximal probe value observed for that 
gene. Samples were then transferred to log-space by taking log2(intensity).
Differentially expressed genes (comparing to the Th0 control) were found using a method 
we previously described (Yosef et al., 2013). Briefly, genes that were detected in two of the 
four methods used were defined as differentially expressed: (1) Fold change. Requiring a 2-
fold change (up or down) during at least two time points. (2) Polynomial fit. We used the 
EDGE software (Leek et al., 2006; Storey et al., 2005), designed to identify differential 
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expression in time course data, with a threshold of q-value ≤ 0.01. (3) Sigmoidal fit. We used 
an algorithm similar to EDGE while replacing the polynomials with a sigmoid function, 
which is often more adequate for modeling time course gene expression data (Chechik and 
Koller, 2009). We used a threshold of q-value ≤ 0.01. (4) ANOVA. Gene expression was 
modeled by time (using only time points for which we have more than one replicate) and 
treatment. The model takes into account each variable independently, as well as their 
interaction. We report cases in which the P value assigned with the treatment parameter or 
the interaction parameter passed an FDR threshold of 0.01.
To associate the regulation activity of a differentially expressed transcription factor with the 
three phases of IL-10 expression (latency, induction and maintenance) we segmented our 
time course dataset into three corresponding time windows: 0-20h, 25-48h and 54-72h. TFs 
were assigned to specific phases if they were differential expressed (> 1.8 Fold change) 
anytime during this time window.
Prediction of TFs regulating the IL-27 network: Using approaches as we previously 
described (Yosef et al., 2013), we identified potential regulators of Tr1 differentiation by 
computing overlaps between their putative targets and sets of differentially expressed genes 
grouped by k-means clustering. For every TF in our database, we computed the statistical 
significance of the overlap between its putative targets and each of the groups defined above 
using Fisher’s exact test. We included cases where p < 5 × 10−5 and the fold enrichment > 
1.5.
Population RNA-seq data pre-processing and analysis: RNA-seq reads were aligned 
using Tophat (Trapnell et al., 2009) and RSEM-based quantification (Li and Dewey, 2011) 
using known transcripts (mm9), followed by further processing using the Bioconductor 
package DESeq2 in R (Anders and Huber, 2010). The data was normalized using TMM 
normalization. The TMM method estimates scale factors between samples that can be 
incorporated into currently used statistical methods for DE analysis. Post-processing and 
statistical analysis was carried out in R (Li and Dewey, 2011).
For the analysis of the effect of different regulator KOs, differentially expressed genes were 
defined as genes with abs (logFC between control and KO) > 1.
For comparison between IL-10+ and IL-10− cells, differentially expressed genes were 
defined based on the raw counts with a single call to the function DESeq2 (Love et al., 2014) 
(FDR-adjusted P value < 0.05). Heatmap figures were generated using pheatmap package 
(https://cran.r-project.org/web/packages/pheatmap/index.html).
ATAC-seq analysis: Generation and analysis of ATAC-seq data for in-vitro differentiated 
Tr1 cells at 24 h and 72 h were performed in our previously published study (Karwacz et al., 
2017). A publicly available ATAC-seq pipeline (Lee et al., 2016) was used for the processing 
of ATAC-seq on Prdm1 cKO, Maf cKO and DKO Tr1 cells. Briefly, reads were aligned to 
the mm10 genome using Bowtie2 and filtered to remove duplicates and mitochondrial reads. 
Biological replicate for each group were merged peaking-calling using MACS2 (Zhang et 
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al., 2008). Integrative Genomics Viewer (IGV) was used for visualization of ATAC-seq 
peaks.
Single cell RNA-seq analysis
Data preprocessing.: De-multiplexing, alignment to the mm10 mouse transcriptome and 
UMI-collapsing were performed using the Cellranger toolkit (version 2.1.0, 10X Genomics). 
Subsequent analysis was performed with R package Seurat v3 (Butler et al., 2018). For 
downstream processing we filtered out low quality cells that had (1) a low number (< 500) of 
unique detected genes, and (2) a high mitochondrial content (15%) determined by the ratio 
of reads mapping to the mitochondria. A small proportion of cells were identified as 
contamination by macrophages, innate lymphoid cells, intraepithelial lymphocytes and 
fibroblasts, and were excluded from downstream analysis. To account for differences in 
sequencing depth across cells, UMI counts were normalized by the total number of UMIs 
per cell and converted to transcripts-per-10,000 before being log transformed (henceforth 
“log(TP10K+1)”).
PCA and clustering: Highly variable genes were selected using the ‘mean.var.plot’ method 
in FindVariableFeatures function with default settings, resulting in 341 genes which are then 
used for PCA analysis by RunPCA function. We used the first 40 PCs for subsequent 
analyses as they capture the majority of signal in an elbow plot, but we also confirmed that 
the resulting analyses were not particularly sensitive to the above-mentioned choice of 
parameters. The cells were clustered via Seurat’s FindClusters function, which optimizes 
modularity on a K-nearest-neighbor (KNN) graph computed from the top eigenvectors using 
Louvain algorithm, with nn.eps at 0.5, resolution at 0.4, and n.start at 10. These parameters 
resulted in clusters that captured major genotype- related separations, known T cell 
subgroups, and statistically validated transcriptional distinct sections of interest while 
avoiding subdivisions of relatively uniform parts of the data. To visualize the data, UMAP 
plots were generated using Seurat’s RunUMAP function with min.dist at 0.75.
Cell type assignment: To identify which T cell subtype each cluster represents, we 
identified markers of each cluster using Seurat’s FindAllMarkers function with min.pct at 
0.25. The top 200 genes of each cluster were then used as input for My Geneset module of 
Immgen (immgen.org). We assigned identity to each cluster based on the cell population in 
the Immgen database that display highest expression of its marker genes and confirmed the 
designation by expression of known marker genes (Figure S5A).
Gene signatures: Scoring gene signature was performed using AddModuleScore function 
of Seurat based on strategies described by Tirosh et al. (2016). Markers of cell cycles 
including G2/M phase and S phase were provided by Tirosh et al. (2016). Th1 signature was 
manually curated based on literature. Th17 signature was generated by comparing 
microarrays of in vitro cultured Th17 cells to other T helper cells, including naive, Th1, Th2, 
iTreg and nTreg cells (Wei et al., 2009; Xiao et al., 2014). CD4 T cells signature from 
ulcerative colitis patients contains genes upregulated in CD4 T cells from biopsies of 
inflamed intestinal tissue in patients compared to those from healthy tissue in healthy 
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controls profiled by scRNA-seq (Smillie et al., 2019). IBD associated GWAS genes were 
compiled from literature (Graham and Xavier, 2020).
Differential expression analysis: Differentially expressed genes were tested using MAST 
(Finak et al., 2015) by calling FindMarkers function in Seurat. To find unique markers for 
Prdm1/Maf DKO Tregs, DKO Tregs were compared against Treg cells in both single KO 
and control groups.
QUANTIFICATION AND THE STATISTICAL ANALYSIS
Unless otherwise specified, all statistical analyses were performed using the two-tail 
Student’s t test using GraphPad Prism software. P value less than 0.05 is considered 
significant (p < 0.05 = *; p < 0.01 = **; p < 0.001 = ***, p < 0.0001 = ****. Data were 
represented as mean ± s.e.m. unless otherwise specified. For certain types of numeric 
computations for transcriptomic data, the smallest P value that R can report is < 2.2 × 10−16.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• IL-27-driven transcriptional network in CD4 T cells unravels key Il10 
regulators
• Systematic characterization of the function of 16 Il10 regulators by RNA-seq
• Identification of transcription factors associated with Il10 in multiple T cell 
subsets
• Prdm1 and Maf are critical for Il10 production and intestinal immune 
homeostasis
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Figure 1. Building a Predicative Model of the IL-27-Driven Transcriptional Program in CD4 T 
Cells by High-Resolution Temporal Transcriptional Profiling
Gene expression profiles during IL-27-driven in-vitro Tr1 differentiation were measured by 
microarray at 17 time points with the Th0 condition as a control.
(A) Relative expression (log2(Tr1/Th0)) of 790 differentially expressed genes (rows).
(B) Pearson correlation matrix of the transcriptome at every pair of time points.
(C) Relative expression (log2(Tr1/Th0)) of 79 TFs predicted to regulate gene clusters. 
Underlined are TFs known to regulate Tr1 differentiation.
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Figure 2. Experimental Validation of IL-27 Predicative Network Identifies TFs that Regulate 
Il10 In Vitro and In Vivo
(A) Log2 fold change of Il10 mRNA levels in WT versus KO Tr1 cells differentiated in vitro 
with IL-27 for 72 h, quantified by qPCR. Blue, positive regulator; red, negative regulator; 
gray, not statistically significant. Data are displayed as mean of 2–3 replicates.
(B) Statistically significant ChIP-seq binding sites of ATF-3 ATF-3, Fosl2, T-bet, and IRF8 
in the Il10 locus.
(C) Luciferase activity in 293T cells transfected with luciferase reporters for the indicated 
cis-regulatory elements of Il10 and plasmids encoding the depicted TFs. Firefly luciferase 
activity is normalized to constitutive Renilla luciferase activity.
(D) WT and Hlx+/− mice were injected intraperitoneally (i.p.) with anti-CD3. Il10 mRNA in 
CD4+ T cells MACS purified from mesenteric lymph nodes was measured by qPCR.
(E) 5 x 105 in vitro differentiated WT (diamonds) and Hlx+/−(squares) Tr1 cells were 
transferred i.p. into Rag1−/− recipients. Rag1−/− (circles) did not receive any cells. Changes 
in body weight were monitored weekly. n = 5.
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Figure 3. A Comprehensive Transcriptional Network Focused on Regulation of IL-10 by IL-27
(A) General network of Il10 regulation by TFs in Tr1 cells, visualized using Cytoscape. 
Edges indicate causal regulatory targets identified using genetic perturbation by RNA-seq or 
qPCR. Blue and red edges indicate positive and negative regulations, respectively. Nodes are 
colored by betweenness centrality score.
(B) Betweenness centrality scores of the regulators in (A). Blue, positive regulator; red, 
negative regulator.
(C) Temporal expression of Il10 in Tr1 versus Th0 cells measured by microarray.
(D) Temporal regulation of Il10 in Tr1 cells, divided into 3 main phases: latency (0–20 h), 
induction (25–48 h), and maintenance (54–72 h). Purple nodes, increased by IL-27; gray 
nodes, decreased by IL-27.
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Figure 4. Prdm1 and Maf Have Complementary but Indispensable Roles in Regulating Tr1 
Identity at the Transcriptional and Chromatin Level
(A) Naive CD4 T cells from the indicated mice were differentiated in vitro into Tr1 cells 
with IL-27. Il10 expression was measured by qPCR on day 3.
(B and C) Control, Prdm1 cKO, Maf cKO, and Prdm1/Maf DKO Tr1 cells generated as 
described in (A) were analyzed by RNA-seq (B) and ATAC-seq (C).
(B) Heatmap showing expression of 79 predicted regulators in the Tr1 network. “+” 
indicates statistically significant differential expression.
(C) Chromatin accessibility in the Il10, Fosl2, and Hlx loci in Tr1 cells of the indicated 
genotype. Red bars represent regions with differential chromatin accessibility in DKO cells.
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Figure 5. TFs Associated with IL-10 Production in Different T Helper Cells
(A and C) TFs enriched in the IL-10+ compartments compared with their IL-10− 
compartments in (A) in-vitro-generated T helper cell subsets, (C) 10 in vivo/ex vivo 
conditions where a direct comparison between the transcriptome of IL-10+ and IL-10− cells 
was made in public data (Table S1). TFs that are enriched under at least 3 conditions were 
magnified.
(B and D) A different display of same data in (A) and (C), respectively, showing TFs that are 
enriched under at least 3 conditions and the conditions where their expression is enriched in 
the IL-10+ compartment. SI, small intestine.
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(E) A ranking scheme (STAR Methods) for all potential regulators of IL-10, taking into 
account network centrality (Figure 3B), enrichment in in vitro conditions (Figure 5A), and 
enrichment in public datasets (Figure 5C).
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Figure 6. Prdm1 and Maf Synergistically Regulate IL-10 in All T Helper Cells
(A) Enrichment of Prdm1 and Maf mRNA in in-vitro-generated T helper cells validated by 
qPCR.
(B) ChIP-seq of Maf in Th17 cells and Prdm1 in tissue-resident memory T cells aligned with 
ATAC-seq data of Tr1 cells differentiated in vitro at 72 h.
(C) Luciferase activity in 293T cells transfected with Il10 luciferase reporters along with 
constructs encoding Prdm1, Maf, or both. n = 3.
(D) T helper cells differentiated in vitro were transduced with two retroviruses expressing 
Prdm1 and Maf, respectively. IL-10 expression in control cells, Prdm1-overexpressing cells, 
Maf-overexpressing cells, and cells overexpressing Prdm1 and Maf was measured by flow 
cytometry 48 h after transduction.
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Figure 7. Genetic Deficiency of Prdm1 and Maf, but Not Either Alone, in T Cells Leads to 
Human IBD-like Spontaneous Colitis Driven by a Unique Cluster of Treg Cells
(A) Weekly monitored body weights. Top: female mice. Bottom: male mice. n ≥ 8. Data are 
represented as mean ± SD.
(B) Colon length of the indicated mice, presented as seen by gross anatomy and 
measurement.
(C) Hematoxylin and eosin staining of colon Swiss rolls. Pictures are representative of 10 
control, 4 Prdm1 cKO, 6 Maf cKO, and 7 DKO mice. Scale bars represent 250 μm.
(D–K) CD4 T cells from colonic lamina propria were profiled by scRNA-seq.
(D and E) Uniform manifold approximation and projection (UMAP) plots show 13,535 cells 
(dots) colored by genotype (D) or cluster (E).
(F) Distribution of cells with different genotypes in clusters.
(G and H) Left: distribution of gene signature scores of Tconv cells (clusters 1–4) by 
genotype. “+” indicates median. (H) right: enrichment of IBD-associated GWAS genes that 
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are involved in adaptive immunity in differentially expressed genes of Prdm1 cKO, Maf 
cKO, and DKO Tconv cells, respectively, compared with the control. Significance of 
enrichment was tested by hypergeometric test.
(I-K) Gene expression level represented as log(TP10K+1).
(I) Il10 expression by control (WT) cells across clusters.
(J) Il10 expression by Treg cells (clusters 5–8) across genotypes.
(K) Representative differentially expressed genes of DKO Treg cells compared with all other 
genotypes. Dot size represents the fraction of cells in the cluster that express the gene; color 
indicates mean expression in expressing cells relative to other genotypes.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
InVivoMab anti-mouse CD3ε Bio X Cell Cat# BE0001-1
InVivomAb anti-mouse CD28 Bio X Cell Cat# BE0015-5
InVivomAb anti-mouse TGF-β Bio X Cell Cat# BE0057
InVivomAb polyclonal Armenian hamster IgG Bio X Cell Cat# BE0091
Chemicals, Peptides, and Recombinant Proteins
Recombinant Mouse IL-27 (NS0-expressed) Protein R&D SYSTEMS Cat# 2799-ML-010
Recombinant Mouse IL-12 Protein R&D SYSTEMS Cat# 419-ML-050
Mouse IL-4, research grade Miltenyi Biotec Cat# 130-097-757
Recombinant Mouse IL-1 beta/IL-1F2 Protein R&D SYSTEMS Cat# 419-ML-010
Recombinant Mouse IL-6 Protein R&D SYSTEMS Cat# 406-ML-025
Recombinant Mouse IL-23 Protein R&D SYSTEMS Cat# 1887-ML-010
Human TGF-β1, premium grade Miltenyi Biotec Cat# 130-095-067
Liberase TL Research Grade Sigma Cat# 5401020001
DNase I Sigma Cat# 10104159001
Fixable viability dye eFluor506 eBioscience Cat# 65-0866-14
7AAD BD Biosciences Cat# 559925
Digitonin Promega Cat# G9441
Critical Commercial Assays
RNeasy Plus Mini Kit QIAGEN Cat# 74134
iScript Reverse Transcription Supermix Bio-Rad Cat# 1708841
TaqMan Fast Advanced Master Mix Thermo Fisher Scientific Cat# 4444557
PolyJet In Vitro DNA Transfection Reagent SignaGen Laboratories Cat# SL100688
Dual-Luciferase® Reporter Assay System Promega Cat# E1960
GeneChip Mouse Genome 430 2.0 Array Affymetrix Cat# 900497
Nextera® DNA Sample Preparation Kit Illumina Cat# FC-121-1030
MinElute Reaction Cleanup kit QIAgen Cat# 28204
Chromium Single Cell 3′ Library & Gel Bead Kit v2 10x Genomics Cat# PN-120237
Chromium Single Cell A Chip Kit 10x Genomics Cat# PN-1000009
Deposited Data
Raw and analyzed data This paper GEO: GSE159208
Tr1 ATAC-seq (related to Figures 2B and 6B) Karwacz et al., 2017 GEO: GSE92993
Atf3 ChIP-seq (related to Figure 2B) Garber et al., 2012 GEO: GSE36104
Fosl2 ChIP-seq (related to Figure 2B) Ciofani et al., 2012 GEO: GSE40918
Tbx21 ChIP-seq (related to Figure 2B) Nakayamada et al., 2011 GEO: GSE33802
Irf8 ChIP-seq (related to Figure 2B) Xu et al., 2015 GEO: GSE70712
Experimental Models: Cell Lines
293T cells GenHunter Cat# Q401
Platinum-E (Plat-E) Retroviral Packaging Cell Line Cell Biolabs Cat# RV-101
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REAGENT or RESOURCE SOURCE IDENTIFIER
Experimental Models: Organisms/Strains
Mouse: C57BL/6J The Jackson Laboratory JAX: 000664
BALB/cJ The Jackson Laboratory JAX: 000651
Mouse: Foxp3-GFP Bettelli et al., 2006 N/A
Mouse: 10BiT Maynard et al., 2007 N/A
Mouse: Prdm1f/f Shapiro-Shelef et al., 2003 JAX: 008100
Mouse: Maff/f Wende et al., 2012 N/A
Mouse: Ahr KO Schmidt et al., 1996 JAX: 002831
Mouse: Atf3f/f Taketani et al., 2012 N/A
Mouse: Batf KO Schraml et al., 2009 JAX: 013758
Mouse: Cebpbf/f Sterneck et al., 2006 N/A
Mouse: Ets1 KO Muthusamy et al., 1995 N/A
Mouse: Fosl2f/f Karreth et al., 2004 N/A
Mouse: Hif1af/f Ryan et al., 2000 JAX:007561
Mouse: Irf1 KO Matsuyama et al., 1993 JAX: 002762
Mouse: Irf4 KO Klein et al., 2006 JAX: 009380
Mouse: Irf8f/f Feng et al., 2011 JAX:014175
Mouse: Irf9 KO Gift from Paul J. Utz RIKEN: RBRC00915
Mouse: Nfil3f/f Gascoyne et al., 2009 N/A
Mouse: Stat3f/f Moh et al., 2007 JAX: 016923
Mouse: Tbx21 KO Finotto et al., 2002 JAX: 004648
Mouse: Bhlhe40 KO Jiang et al., 2008 JAX: 029732
Mouse: Hlx+/− Hentsch et al., 1996 JAX: 008313
Mouse: Stat4 Kaplan et al., 1996 JAX: 002826
Mouse: Batf3 KO Hildner et al., 2008 JAX: 013755
Mouse: Nfe2l2 KO Chan et al., 1996 JAX: 017009
Mouse: Irf7 KO Gift from Ian Rifkin N/A
Mouse: Id2f/f Seillet et al., 2013 N/A
Mouse: Fli1+/− Gift from Maria Trojanowska N/A
Mouse: Cd4-Cre Lee et al., 2001 Taconic: 4196
Mouse: Actin-Cre Lewandoski et al., 1997 JAX: 033984
Mouse: Lck-Cre Hennet et al., 1995 JAX: 003802
Mouse: dLck-Cre Wang et al., 2001 JAX: 012837
Recombinant DNA
pGL4.10[luc2] Vector Promega Cat# E665A
pGL4.10-Il10 proximal promoter-luc2 This paper N/A
pGL4.10-Il10 CNS-9-luc2 This paper N/A
pGL4.10-Il10 HSS+2.98-luc2 This paper N/A
pGL4.10-Il10 HSS+6.45-luc2 This paper N/A
MSCV-IRES-GFP Gift from Tannishtha Reya Addgene #20672
MSCV-Maf-IRES-GFP This paper N/A
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REAGENT or RESOURCE SOURCE IDENTIFIER
MSCV-IRES-Thy1.1 Gift from Philippa Marrack N/A
MSCV-Prdm1-IRES-Thy1.1 This paper N/A
Software and Algorithms
GenePattern Reich et al., 2006 https://www.genepattern.org/
EDGE Leek et al., 2006 https://www.bioconductor.org/
Tophat Trapnell et al., 2009 https://github.com/infphilo/tophat
RSEM Li and Dewey, 2011 http://deweylab.github.io/RSEM/
DESeq2 Love et al., 2014 https://bioconductor.org/packages/release/bioc/html/
DESeq2.html
RStudio RStudio https://www.rstudio.com/
ATAC-seq pipeline Lee et al., 2016 https://zenodo.org/record/211733
Integrative Genomics Viewer Robinson et al., 2017 http://software.broadinstitute.org/software/igv/
R package Seurat v3 Butler et al., 2018 https://satijalab.org/seurat/
FlowJo FlowJo https://www.flowjo.com
Prism GraphPad https://www.graphpad.com
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